Qingdao Vland Biotech INC. (SHA:603739)

SHA:603739 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,504	3,034	3,851	3,387	4,689	3,474
Market Cap Growth	10.73%	-21.22%	13.69%	-27.76%	34.98%	-12.09%
Enterprise Value	3,872	3,413	4,153	3,512	4,417	3,328
Last Close Price	13.85	11.90	15.01	13.14	18.01	15.41
PE Ratio	57.45	48.44	47.72	48.50	35.37	31.88
Forward PE	42.40	30.10	29.41	15.83	-	-
PS Ratio	2.61	2.30	3.21	2.91	4.07	3.62
PB Ratio	1.87	1.62	2.11	1.95	2.78	3.12
P/TBV Ratio	2.29	1.99	2.59	2.28	3.23	3.85
P/FCF Ratio	39.88	33.45	-	-	-	-
P/OCF Ratio	16.18	15.53	25.07	35.54	52.38	20.08
EV/Sales Ratio	2.88	2.58	3.46	3.02	3.84	3.47
EV/EBITDA Ratio	16.52	15.18	23.48	24.16	24.35	21.52
EV/EBIT Ratio	33.71	29.83	40.27	44.08	34.05	29.77
EV/FCF Ratio	44.06	37.64	-	-	-	-
Debt / Equity Ratio	0.38	0.34	0.40	0.30	0.14	0.06
Debt / EBITDA Ratio	3.02	2.83	4.09	3.60	1.30	0.44
Debt / FCF Ratio	8.06	7.01	-	-	-	-
Asset Turnover	0.44	0.44	0.43	0.49	0.63	0.70
Inventory Turnover	3.64	3.69	3.42	4.01	4.40	4.29
Quick Ratio	0.82	0.83	0.82	1.19	2.08	2.06
Current Ratio	1.04	1.04	1.03	1.50	2.61	2.72
Return on Equity (ROE)	4.93%	4.99%	5.78%	5.00%	10.72%	11.39%
Return on Assets (ROA)	2.37%	2.38%	2.30%	2.08%	4.42%	5.11%
Return on Capital (ROIC)	2.78%	2.83%	2.68%	2.38%	5.22%	6.21%
Return on Capital Employed (ROCE)	5.80%	5.90%	5.30%	4.10%	7.00%	9.50%
Earnings Yield	1.70%	2.07%	2.10%	2.06%	2.83%	3.14%
FCF Yield	2.51%	2.99%	-1.61%	-7.28%	-8.62%	-1.12%
Dividend Yield	0.72%	0.84%	0.67%	0.76%	0.89%	0.93%
Payout Ratio	92.15%	88.18%	49.28%	75.55%	28.50%	29.87%
Buyback Yield / Dilution	1.21%	0.66%	2.50%	-5.36%	-8.14%	-6.37%
Total Shareholder Return	1.95%	1.50%	3.16%	-4.60%	-7.25%	-5.45%

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.